Literature DB >> 15014625

SSRI Antidepressant Medications: Adverse Effects and Tolerability.

James M. Ferguson1.   

Abstract

Side effects of antidepressants can be predicted by receptor selectivity and site of action. Although the selective serotonin reuptake inhibitors (SSRIs) have better overall safety and tolerability than older antidepressants, broad-based experience with SSRIs has shown the frequency and type of side effects to be increased relative to clinical trial data. The author explores the reasons for the different profiles and discusses adverse effects, especially sexual dysfunction, weight gain, and sleep disturbance, the most troubling adverse events seen during long-term SSRI therapy. The informed management of these side effects by primary care practitioners supports successful treatment of depression.

Entities:  

Year:  2001        PMID: 15014625      PMCID: PMC181155          DOI: 10.4088/pcc.v03n0105

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN: 1523-5998


  18 in total

Review 1.  Selective serotonin reuptake inhibitors and hyponatraemia: review and proposed mechanisms in the elderly.

Authors:  V Kirchner; L E Silver; C A Kelly
Journal:  J Psychopharmacol       Date:  1998       Impact factor: 4.153

Review 2.  The SSRI discontinuation syndrome.

Authors:  P Haddad
Journal:  J Psychopharmacol       Date:  1998       Impact factor: 4.153

3.  Adverse reactions of selective serotonin reuptake inhibitors: reports from a spontaneous reporting system.

Authors:  O Spigset
Journal:  Drug Saf       Date:  1999-03       Impact factor: 5.606

4.  SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability.

Authors:  I M Anderson
Journal:  Depress Anxiety       Date:  1998       Impact factor: 6.505

5.  Anorgasmia from clomipramine in obsessive-compulsive disorder. A controlled trial.

Authors:  W O Monteiro; H F Noshirvani; I M Marks; P T Lelliott
Journal:  Br J Psychiatry       Date:  1987-07       Impact factor: 9.319

6.  Incidence and risk factors for hyponatraemia following treatment with fluoxetine or paroxetine in elderly people.

Authors:  T J Wilkinson; E J Begg; A C Winter; R Sainsbury
Journal:  Br J Clin Pharmacol       Date:  1999-02       Impact factor: 4.335

Review 7.  Mirtazapine: a review of its use in major depression.

Authors:  K J Holm; A Markham
Journal:  Drugs       Date:  1999-04       Impact factor: 9.546

8.  Systematic review and guide to selection of selective serotonin reuptake inhibitors.

Authors:  J G Edwards; I Anderson
Journal:  Drugs       Date:  1999-04       Impact factor: 9.546

Review 9.  Selective serotonin reuptake inhibitors in the treatment of affective disorders--III. Tolerability, safety and pharmacoeconomics.

Authors:  B J Goldstein; P J Goodnick
Journal:  J Psychopharmacol       Date:  1998       Impact factor: 4.153

10.  Fluoxetine-induced weight loss in overweight non-depressed humans.

Authors:  J M Ferguson; J P Feighner
Journal:  Int J Obes       Date:  1987
View more
  169 in total

1.  Sexual touching and difficulties with sexual arousal and orgasm among U.S. older adults.

Authors:  Adena M Galinsky
Journal:  Arch Sex Behav       Date:  2011-12-08

2.  Assessing Sexual Function of Patients Before Initiating SSRI Therapy.

Authors:  Timothy R. Berigan
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2001-08

Review 3.  Gynecological management of premenstrual symptoms.

Authors:  Lee P Shulman
Journal:  Curr Pain Headache Rep       Date:  2010-10

4.  Discovery of novel selective serotonin reuptake inhibitors through development of a protein-based pharmacophore.

Authors:  Sankar Manepalli; Laura M Geffert; Christopher K Surratt; Jeffry D Madura
Journal:  J Chem Inf Model       Date:  2011-09-02       Impact factor: 4.956

Review 5.  A Review on Potential Footprints of Ferulic Acid for Treatment of Neurological Disorders.

Authors:  Surabhi Thapliyal; Tanveer Singh; Shailendra Handu; Manisha Bisht; Puja Kumari; Priyanka Arya; Pallavi Srivastava; Ravi Gandham
Journal:  Neurochem Res       Date:  2021-02-05       Impact factor: 3.996

6.  SSRIs and SNRIs: A review of the Discontinuation Syndrome in Children and Adolescents.

Authors:  Sheik Hosenbocus; Raj Chahal
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2011-02

7.  Sexual function improvement in association with serum leptin level elevation in patients with premature ejaculation following sertraline treatment: a preliminary observation.

Authors:  Kun-Long Tang; Bao-Long Wang; Lin Yang; Li-Ming Li; Yong Zhou; Chang-Hai Yang
Journal:  Bosn J Basic Med Sci       Date:  2013-11       Impact factor: 3.363

8.  Patterns of antidepressant use in Italy: therapy duration, adherence and switching.

Authors:  Luca Degli Esposti; Carlo Piccinni; Diego Sangiorgi; Andrea Fagiolini; Stefano Buda
Journal:  Clin Drug Investig       Date:  2015-11       Impact factor: 2.859

9.  Functional and developmental identification of a molecular subtype of brain serotonergic neuron specialized to regulate breathing dynamics.

Authors:  Rachael D Brust; Andrea E Corcoran; George B Richerson; Eugene Nattie; Susan M Dymecki
Journal:  Cell Rep       Date:  2014-12-11       Impact factor: 9.423

Review 10.  The Potential of Gonadal Hormone Signalling Pathways as Therapeutics for Dementia.

Authors:  X Du; R A Hill
Journal:  J Mol Neurosci       Date:  2016-08-15       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.